Replies to post #215813 on Biotech Values

[DewDiligence]

(Revised)—RVNC’s fully-diluted* share count for valuation purposes is 41.9M. This figure consists of: 30.9M basic shares on the 9/30/17 balance sheet (https://www.sec.gov/Archives/edgar/data/1479290/000147929017000042/rvncq31710q.htm#s566245125C215CE2A164C516887ADD48 ); 5.6M options, warrants, and shares reserved (but not yet issued) for employee stock-purchase plans (https://www.sec.gov/Archives/edgar/data/1479290/000119312517363396/d459933d424b5.htm page S-3); and 5.4M shares sold in the public offering on 12/7/17 (including the exercised underwriter’s option).

*Non-treasury method.